Sabra Health Care REIT Inc
NASDAQ:SBRA

Watchlist Manager
Sabra Health Care REIT Inc Logo
Sabra Health Care REIT Inc
NASDAQ:SBRA
Watchlist
Price: 17 USD 0.24%
Market Cap: 4B USD
Have any thoughts about
Sabra Health Care REIT Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one SBRA stock under the Base Case scenario is 25.76 USD. Compared to the current market price of 17 USD, Sabra Health Care REIT Inc is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBRA Relative Value
Base Case
25.76 USD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.8
P/S
P/S
Price to Sales
5.8
vs History
3
vs Industry
33
Median 3Y
4.9
Median 5Y
4.9
Industry
3.6
Forward
5.7
More Details
41.4
P/E
P/E
Price to Earnings
41.4
vs History
30
vs Industry
6
Median 3Y
-22.1
Median 5Y
16.8
Industry
16.7
Forward
32.2
More Details
13
P/OCF
P/OCF
Price to OCF
13
vs History
3
vs Industry
28
Median 3Y
9.4
Median 5Y
8.8
Industry
10.9
More Details
22.9
P/FCFE
P/FCFE
Price to FCFE
22.9
vs History
25
vs Industry
19
Median 3Y
15.8
Median 5Y
12.2
Industry
13.3
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
3
vs Industry
23
Median 3Y
1
Median 5Y
0.9
Industry
0.8
More Details
9.3
EV/S
EV/S
Enterprise Value to Sales
9.3
vs History
7
vs Industry
34
Median 3Y
8.8
Median 5Y
8.8
Industry
6.6
Forward
9.1
More Details
13.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.2
vs History
3
vs Industry
40
Median 3Y
11.6
Median 5Y
11.2
Industry
11.9
More Details
15.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.4
vs History
3
vs Industry
40
Median 3Y
13.3
Median 5Y
12.7
Industry
15.8
Forward
14.7
More Details
26.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
26.1
vs History
3
vs Industry
24
Median 3Y
24.6
Median 5Y
23.1
Industry
19
Forward
24.9
More Details
20.6
EV/OCF
EV/OCF
Enterprise Value to OCF
20.6
vs History
3
vs Industry
29
Median 3Y
16.6
Median 5Y
15.7
Industry
18.5
More Details
40.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
40.3
vs History
3
vs Industry
25
Median 3Y
23.5
Median 5Y
22.6
Industry
20.1
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
3
vs Industry
17
Median 3Y
1
Median 5Y
0.9
Industry
0.7
More Details

Multiples Across Competitors

SBRA Competitors Multiples
Sabra Health Care REIT Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4B USD 5.8 41.4 15.4 26.1
US
Welltower Inc
NYSE:WELL
77.7B USD 10.4 84.9 32.8 79.1
US
Ventas Inc
NYSE:VTR
24.8B USD 5.1 -372.2 17.7 52.1
US
Physicians Realty Trust
NYSE:DOC
14.1B USD 5.5 45.7 14.4 38.1
US
Healthpeak Properties Inc
F:HC5
13.4B EUR 5.5 45.4 14.4 38.1
US
Omega Healthcare Investors Inc
NYSE:OHI
10.2B USD 10.1 29.3 16.3 24.8
US
Healthcare Realty Trust Inc
NYSE:HR
6.4B USD 4.8 -22.8 14.6 211
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 7.1 58.8 18.6 47.7
US
CareTrust REIT Inc
NYSE:CTRE
4.7B USD 17.3 47.1 20.3 26.6
US
National Health Investors Inc
NYSE:NHI
3B USD 9.2 23.8 16.2 22.3
BE
Aedifica NV
XBRU:AED
2.6B EUR 8.1 24 18.5 18.8
P/E Multiple
Earnings Growth P/E to Growth
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
Average P/E: 44.5
41.4
1 210%
0
US
Welltower Inc
NYSE:WELL
84.9
309%
0.3
US
Ventas Inc
NYSE:VTR
Negative Multiple: -372.2 N/A N/A
US
Physicians Realty Trust
NYSE:DOC
45.7
-37%
N/A
US
H
Healthpeak Properties Inc
F:HC5
45.4
-37%
N/A
US
Omega Healthcare Investors Inc
NYSE:OHI
29.3
85%
0.3
US
Healthcare Realty Trust Inc
NYSE:HR
Negative Multiple: -22.8 N/A N/A
US
H
Healthcare Trust Of America Inc
F:HT01
58.8
N/A N/A
US
C
CareTrust REIT Inc
NYSE:CTRE
47.1
417%
0.1
US
National Health Investors Inc
NYSE:NHI
23.8
11%
2.1
BE
Aedifica NV
XBRU:AED
24
889%
0

See Also

Summary
SBRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBRA stock valuation using valuation multiples.
Wall Street Estimates
SBRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.